GO:1903830 magnesium ion transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903830 describes the directed movement of magnesium ions (Mg2+) across a biological membrane, a process essential for cellular Mg2+ homeostasis.
• Magnesium transport is mediated by diverse protein families including CorA, MgtE, CNNM, SLC41A1, and P-type ATPases such as MgtA.
• Dysregulation of Mg2+ transport is linked to electrolyte disorders, mitochondrial dysfunction, pyroptosis, and bone regeneration.
• Structural studies reveal that Mg2+ channels achieve selectivity through defined filter geometry and regulatory domains.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal interrogation of Mg2+ transporters in disease and physiology.
• Studying GO:1903830 requires integrated methods: electrophysiology, fluorescent Mg2+ imaging, proteomics, and transcriptomics.
Description
Magnesium is the second most abundant intracellular cation and serves as a cofactor for hundreds of enzymes, yet its transmembrane movement is tightly controlled. GO:1903830, magnesium ion transmembrane transport, is defined as the directed movement of magnesium ion across a membrane. This process is fundamental to cellular bioenergetics, signaling, and structural integrity. Researchers study it because disturbances in Mg2+ flux underlie conditions ranging from electrolyte disorders to mitochondrial damage and impaired tissue regeneration. The transport machinery includes channels, transporters, and pumps that are conserved from bacteria to humans. Recent structural and functional work has illuminated how these proteins achieve selectivity and regulation, offering targets for therapeutic intervention.
magnesium ion transmembrane transport At A Glance
| GO ID | GO:1903830 |
|---|---|
| GO term | magnesium ion transmembrane transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of Mg2+ across membranes |
| Related transporters | CorA, MgtE, CNNM, SLC41A1, MgtA |
| Associated diseases | Electrolyte disorders, mitochondrial dysfunction, pyroptosis |
| Research methods | Electrophysiology, fluorescent imaging, CRISPR screens |
What Is GO:1903830?
GO:1903830 is a biological process term describing the directed movement of magnesium ions (Mg2+) across a membrane. This includes transport from one side of a lipid bilayer to the other, whether through channels, carriers, or pumps, and encompasses both influx and efflux. The term does not specify mechanism, direction, or cellular location, but rather the net translocation of Mg2+ across a membrane.
Why Is magnesium ion transmembrane transport Important in Cell Biology?
Magnesium ion transmembrane transport is critical for maintaining cellular Mg2+ homeostasis, which influences enzyme activity, energy metabolism, and signal transduction. Defects in this process contribute to a range of pathologies, including electrolyte imbalances, mitochondrial damage, and impaired bone healing. Understanding the molecular players and regulatory mechanisms provides opportunities for therapeutic targeting and for interpreting genetic variants in transport proteins.
• Maintains intracellular Mg2+ concentration required for ATP and nucleic acid metabolism.
• Regulates mitochondrial function and cell survival; SLC41A1-mediated efflux can trigger pyroptosis.
• Influences bone regeneration; magnetic field-enhanced Mg2+ transport from scaffolds promotes osteogenesis.
• Dysregulation leads to electrolyte disorders such as hypomagnesemia.
• Provides targets for antimicrobial and anticancer strategies via bacterial and human transporters.
• Structural insights inform design of selective modulators.
• Essential for neuronal excitability and neuromuscular transmission.
• Plays a role in immune cell function and inflammation.
• Contributes to dental stem cell homeostasis.
• Enables tissue engineering through controlled ion release.
What Happens During magnesium ion transmembrane transport?
Substrate recognition and binding
In simple terms: The transporter first grabs magnesium ions from one side of the membrane.
Magnesium transporters such as CorA and MgtE possess specific binding sites that coordinate Mg2+ with high affinity. Structural studies show that selectivity is achieved through a defined filter geometry that excludes other cations. In CNNM proteins, the Bateman module and cyclic nucleotide-binding homology domain regulate ion binding.
Conformational change and translocation
In simple terms: The protein changes shape to move the ion across the membrane.
Upon binding, transporters undergo conformational changes that shuttle Mg2+ across the lipid bilayer. For example, the P-type ATPase MgtA forms a dimer and uses ATP hydrolysis to drive transport against a gradient. In channels, gating is controlled by regulatory domains that respond to cellular signals.
Ion release and resetting
In simple terms: The ion is released on the other side, and the transporter resets.
After translocation, Mg2+ is released into the cytoplasm or extracellular space, and the transporter returns to its resting state. This cycle is essential for maintaining gradients. In SLC41A1, efflux of Mg2+ from mitochondria can be triggered by LPS-induced damage, leading to pyroptosis.
Regulation by cellular signals
In simple terms: Cells can speed up or slow down magnesium transport based on their needs.
Transport activity is regulated by factors such as magnesium availability, pH, and signaling pathways. For instance, magnetic fields can enhance the transmembrane transport efficiency of Mg2+ from bone scaffolds. Additionally, CNNM proteins are regulated by phosphorylation and nucleotide binding.
Key Genes Involved in GO:1903830 magnesium ion transmembrane transport
The following genes encode proteins that mediate or regulate magnesium ion transmembrane transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC41A1 | Mg2+ efflux transporter | Mitochondrial damage and pyroptosis |
| CNNM2 | Mg2+ transport regulator | Structure-function and disease links |
| CNNM4 | Mg2+ transport regulator | Retinal and neurological disorders |
| MgtA | P-type ATPase Mg2+ importer | Bacterial Mg2+ homeostasis, dimerization |
| CorA | Mg2+ channel | Structural model for selectivity |
| MgtE | Mg2+ channel | Gating and regulation |
| TRPM6 | Mg2+ channel | Epithelial Mg2+ absorption |
| TRPM7 | Mg2+ channel | Cellular Mg2+ homeostasis |
| MMgT | Mg2+ transporter | Golgi and endosomal transport |
| Mrs2 | Mitochondrial Mg2+ channel | Mitochondrial Mg2+ uptake |
| Alr1 | Yeast Mg2+ transporter | Fungal Mg2+ homeostasis |
| AtMGT | Plant Mg2+ transporter | Plant nutrition and stress |
| SLC41A2 | Mg2+ transporter | Intestinal absorption |
| NIPA1 | Mg2+ transporter | Neurological function |
| NIPA2 | Mg2+ transporter | Renal Mg2+ handling |
| NIPA3 | Mg2+ transporter | Uncharacterized |
| NIPA4 | Mg2+ transporter | Uncharacterized |
How Is magnesium ion transmembrane transport Regulated?
Magnesium ion transmembrane transport is regulated at multiple levels. Transcriptional control of transporter genes responds to Mg2+ availability, while post-translational modifications such as phosphorylation modulate activity. For example, CNNM proteins are regulated by nucleotide binding and phosphorylation. In bacteria, MgtA expression is controlled by the PhoPQ system in response to low Mg2+. Additionally, magnetic fields can enhance transport efficiency in bone scaffolds.
magnesium ion transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC41A1 | Pyroptosis in dental stem cells | Knockout in dental stem cells |
| CNNM2 | Hypomagnesemia, seizures | Knock-in of patient mutations |
| CNNM4 | Jalili syndrome | Retinal organoids with knockout |
| TRPM6 | Hypomagnesemia with secondary hypocalcemia | Intestinal epithelial KO |
| MgtA | Bacterial virulence | Bacterial knockout |
Electrolyte disorders
Disturbances in magnesium transport can lead to hypomagnesemia or hypermagnesemia, which manifest as neuromuscular and cardiac symptoms. These disorders often arise from mutations in transporters such as TRPM6 or CNNM2.
Mitochondrial dysfunction and pyroptosis
LPS-induced mitochondrial damage via SLC41A1-mediated Mg2+ efflux triggers pyroptosis in dental stem cells, linking Mg2+ transport to inflammatory cell death.
Bone regeneration
Magnetic field-enhanced Mg2+ transport from PLLA bone scaffolds promotes osteogenesis, suggesting a role for Mg2+ transport in bone healing.
Neurological and retinal disorders
Mutations in CNNM4 cause Jalili syndrome, characterized by cone-rod dystrophy and amelogenesis imperfecta, highlighting the importance of Mg2+ transport in sensory tissues.
From magnesium ion transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC41A1 mediate Mg2+ efflux? | SLC41A1 knockout cells |
| How does CNNM2 mutation affect transport? | Point mutation knock-in |
| Can MgtA dimerization be disrupted? | Point mutation in MgtA |
| Does overexpression of TRPM6 increase Mg2+ uptake? | Overexpression cell line |
| What is the role of CorA selectivity filter? | Knock-in of mutated CorA |
| Can magnetic fields enhance Mg2+ transport? | In vitro scaffold with osteoblasts |
How to Study the magnesium ion transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescent imaging | Intracellular Mg2+ concentration | Live-cell transport assays |
| Patch-clamp | Ion channel currents | Electrophysiology of Mg2+ channels |
| Cryo-EM | Protein structure | Mechanistic studies of transporters |
| CRISPR screen | Gene essentiality and fitness | Identify regulators of Mg2+ transport |
| RNA-seq | Transcriptional changes | Response to Mg2+ stress |
| Proteomics | Protein interactions | Identify transport complexes |
| Atomic absorption spectroscopy | Total Mg2+ content | Quantify transport activity |
Fluorescent Mg2+ imaging
Using dyes such as Mag-Fura-2 or genetically encoded sensors, researchers can monitor real-time Mg2+ flux across membranes in live cells. This method is useful for assessing transport activity and regulation.
Electrophysiology
Patch-clamp and planar lipid bilayer recordings measure ion channel activity directly, revealing conductance, selectivity, and gating of Mg2+ channels such as CorA and MgtE.
Structural biology
X-ray crystallography and cryo-EM provide atomic-resolution structures of transporters, informing mechanism and drug design. Recent work on MgtA dimers and designed Ca2+ channels exemplifies this approach.
CRISPR screening
Genome-wide knockout screens can identify genes that regulate Mg2+ homeostasis or sensitivity to transport inhibitors, uncovering novel players in GO:1903830.
How CRISPR Can Be Used to Study GO:1903830 magnesium ion transmembrane transport
Knockout
CRISPR knockout of Mg2+ transporter genes (e.g., SLC41A1, CNNM2) enables loss-of-function studies to determine their role in cellular Mg2+ homeostasis and disease phenotypes.
Point Mutation
Introducing disease-associated point mutations (e.g., in CNNM4 or MgtA) allows precise modeling of altered transport activity and structural defects.
Knock-in
Knock-in of tagged transporters (e.g., GFP-MgtA) facilitates localization and interaction studies, while knock-in of patient variants creates isogenic disease models.
Overexpression
Overexpression of Mg2+ transporters such as TRPM6 or MgtA can enhance transport capacity, useful for biochemical purification and gain-of-function assays.
How EDITGENE Supports magnesium ion transmembrane transport Research
Researchers studying magnesium ion transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in Mg2+ flux, and how specific mutations alter transport activity. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for magnesium ion transmembrane transport research.
Frequently Asked Questions About magnesium ion transmembrane transport
What is magnesium ion transmembrane transport?
It is the directed movement of magnesium ions across a membrane, defined by GO:1903830.
What genes are involved in magnesium ion transmembrane transport?
Key genes include SLC41A1, CNNM2, CNNM4, MgtA, CorA, MgtE, TRPM6, TRPM7, and others.
How is magnesium ion transmembrane transport regulated?
It is regulated by Mg2+ availability, phosphorylation, nucleotide binding, and signals like magnetic fields.
What diseases are linked to defects in magnesium transport?
Hypomagnesemia, Jalili syndrome, mitochondrial dysfunction, and pyroptosis.
What methods study magnesium ion transmembrane transport?
Fluorescent imaging, patch-clamp, cryo-EM, CRISPR screens, and proteomics.
Can CRISPR be used to study magnesium transporters?
Yes, knockout, point mutation, knock-in, and overexpression models are widely used.
What is the role of SLC41A1 in magnesium transport?
SLC41A1 mediates Mg2+ efflux and its dysfunction leads to mitochondrial damage and pyroptosis.
How does CNNM2 regulate magnesium?
CNNM2 is a Mg2+ transporter regulated by phosphorylation and nucleotide binding, mutations cause hypomagnesemia.
What is the structure of magnesium channels?
They have selectivity filters that coordinate Mg2+ with high specificity, as shown for CorA and MgtE.
Why is magnesium transport important for bone?
Magnetic field-enhanced Mg2+ transport from scaffolds promotes bone regeneration.
Conclusion
GO:1903830 magnesium ion transmembrane transport is a fundamental biological process with far-reaching implications for cellular physiology and disease. The diverse families of Mg2+ transporters, their regulatory mechanisms, and their links to pathologies such as electrolyte disorders and mitochondrial dysfunction make them attractive research targets. Advances in structural biology and CRISPR-based models continue to unravel the complexities of Mg2+ flux, offering new avenues for therapeutic intervention.
References
- 1. Yan Z et al.. 2023. Magnetic Field Boosts the Transmembrane Transport Efficiency of Magnesium Ions from PLLA Bone Scaffold.. Small 19(40):e2301426 PMID: 37271895
- 2. Girndt M. 2011. [Electrolyte disorders].. Internist (Berl) 52(8):963-74; quiz 975 PMID: 21681474
- 3. Liu Y et al.. 2025. LPS-Induced Mitochondrial Damage via SLC41A1-Mediated Magnesium Ion Efflux Leads to the Pyroptosis of Dental Stem Cells.. Adv Sci (Weinh) 12(42):e05666 PMID: 40831212
- 4. Liu Y et al.. 2025. Bottom-up design of Ca(2+) channels from defined selectivity filter geometry.. Nature 648(8093):468-476 PMID: 41125887
- 5. Payandeh J et al.. 2013. The structure and regulation of magnesium selective ion channels.. Biochim Biophys Acta 1828(11):2778-92 PMID: 23954807
- 6. Chen YS et al.. 2023. New insights into the structure and function of CNNM proteins.. FEBS J 290(23):5475-5495 PMID: 37222397
- 7. Zeinert R et al.. 2025. P-type ATPase magnesium transporter MgtA acts as a dimer.. Nat Struct Mol Biol 32(9):1633-1643 PMID: 40550995
- 8. Maguire ME. 2006. Magnesium transporters: properties, regulation and structure.. Front Biosci 11:3149-63 PMID: 16720382
